Age and gender associated changes in cystatin C and Beta2-microglobulin

Age and gender associated changes in cystatin C and Beta2-microglobulin

Assessment of renal function in clinical medicine is of great importance. Various studies report that cystatin C (cysC) and beta 2 -microglobulin are valuable markers of renal function. In this study, serum cysC and beta 2 -microglobulin were measured in parallel with serum creatinine in a healthy population, and the characteristics of the relationship of cysC and beta 2 -microglobulin to age and gender were compared. Serum creatinine, cysC and b2-microglobulin were measured in 119 (86 female; 33 male, 6 to 69 years old) healthy subjects. They were divided into five different age groups: group 1 (6-15 years, n = 10), group 2 (16-30 years, n = 34), group 3 (31-45 years, n = 34), group 4 (46-60 years, n = 29) and group 5 (>61 years, n = 12). Serum creatinine did not differ among groups and was not correlated with age. Creatinine values were significantly different (p = 0.004) between males and females. CysC values differed neither by gender nor by age in the groups. However, cysC exhibited a positive correlation with age (r = 0.212, p = 0.021). b 2 -microglobulin levels showed a significant difference between groups (p = 0.036). There was a positive correlation between serum b 2 -microglobulin and age (r = 0.188, p = 0.041). In conclusion, serum cysC and b 2 -microglobulin levels in healthy individuals increase with ageing, consistent with the decrease in GFR.

___

  • 1. Lindeman RD. Assessment of renal function in the old. Clin Lab Med 13:269-277, 1993.
  • 2. Meyer BR, Bellucci A. Renal function in the elderly. Cardiol Clin 4:227-234, 1986.
  • 3. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin Chem 38:1933-1953, 1992.
  • 4. Payne RB. Creatinine clearance: a redundant clinical investigation. Ann Clin Biochem 23:243-250, 1986.
  • 5. Spencer K. Analytical reviews of clinical biochemistry: the estimation of creatinine. Ann Clin Biochem 23:1-25, 1986.
  • 6. Grubb A, Simonsen O, Storfelt G, Truedsson L, Thysell H. Serum concentration of cystatin C, factor D and beta 2-microglobulin as a measure of glomerular filtration rate. Acta Med Scand 218:499-503, 1985.
  • 7. Schardijn GHC, Statius van Eps WE. Beta 2-microglobulin: its significance in the evaluation of renal function. Kidney" Int 32:635-641, 1987.
  • 8. Tramonti G, Donadio C, Ferdeghini M, Annichiarico C, Norpoth M, Bianchi R, Bianchi C. Serum tumour-associated trypsin inhibitor (TAT1) and renal function. Scand J Clin Lab Invest 56:653-656, 1996.
  • 9. Kyhse-Andersen J, Schmidt C, Nordin C, Andersson B, Nilsson-Ehle P, Lindstrom V, Grubb A. Serum cystatin C, determined by a rapid, automated particle-enhanced turbidimetric method, is a better marker than serum creatinine for glomerular filtration rate. Clin Chem 40:1921-1926, 1994.
  • 10. Le Bricon T, Thervet E, Benlakehal M, Bousquet B, Legendre C, Erlich D.Le Bricon T, Thervet E. Changes in plasma cystatin C after renal transplantation and acute rejection in adults. Clin Chem 45:2243-2249, 1999.
  • 11. Bianchi C, Donadio C, Tramonti G, Consani C, Lorusso P, Rossi G. Reappraisal of serum beta2- microglobulin as marker of GFR. Ren Fail 23:419-29, 2001.
  • 12. Henskens YMC, Veerman ECl, Nieuw Amerongen AV. Cystatins in health and disease. Biol Chem Hoppe-Seyler 377:71-86,1996.
  • 13. Abrahamson K, Olafsson I, Palsdottir A, Ulvsback M, Lundwall A, Hensson 0, Grubb A. Structure and expression of the human cystatin C gene. Biochem J 268:287-94, 1990.
  • 14. Henne V, Frei P, Bürgisser P. Beta2- microglobulin- a rapid and automated determination for a broad range of clinical applications. Anticancer Res 17:2915-2918, 1997.
  • 15. Larsen K. Creatinine assay by a reaction- kinetic approach. Clin Chim Acta 41:209-217, 1972.
  • 16. Dunnill MS, Halley W. Some observations on the quantitative anatomy of the kidney. J Pathol 110:113-121, 1973.
  • 17. Swan SK. The search continues- an ideal marker of GFR. Clin Chem 1997; 43:913-4.
  • 18. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976.
  • 19. Baracskay D, Jarjoura D, Cugino A, Blend D, Rutecki GW, Whittier FC. Geriatric renal function: estimating giomeruiar filtration in an ambulatory elderly . population. Clin Nephrol 47:222-228, 1997.
  • 20. Donadio C, Lucchesi A, Ardini L, Ardini M, Giordani R. Cystatin C, β2- microglobulin, and retinol-binding protein as indicators of giomeruiar filtration rate: comparison with plasma creatinine. J Pharm Biomed Anal 24:835-842,2001.
  • 21. Cameron CS, Greger R. Renal function and testing of function. In: Davidson AM, Cameron JS, Grünfeid J-P, et al. Oxford Textbook of Clinical Nephrology. Oxford: Oxford University Press, 1998: 1.3:39-69.
  • 22. Finney H, Bates CJ, Price CP. Plasma cystatin C determinations in a healthy elderly population. Arch Gerontol Geriatr 29:75-94, 1999.
  • 23. Norlund L, Fex G, Lanke J, von Schenke H, Nilsson JE, Leksell H, Grubb A. Reference intervals for the giomeruiar filtration rate and cell-proliferation markers: serum cystatin C and serum β2-microglobulin/cystatin C ratio. Scand J Clin Lab Invest 57:463-470, 1997.
  • 24. Erlandsehn EJ, Randers E, Kristensen JH. Reference intervals for serum cystatin C and serum creatinine in adults. Clin Chem Lab Med 36:393- 397, 1998.
  • 25. Keevil BG, Kilpatrick ES, Nichols SP, Maylor PW. Biological variation of cystatin C: implications for the assessment of giomeruiar filtration rate. Clin Chem 44:1535-1539, 1998.
  • 26. Nolte S, Mueller B, Pringsheim W. Serum a1-microglobulin and beta2- microglobulin for the estimation of fetal giomeruiar renal function. Pediatr Nephrol 5:573-7, 1991.